aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
EarlyCell is a biotechnology company focused on developing genetic and expression diagnostics for unmet or poorly diagnosed conditions. Utilizing advanced technologies such as NGS, microarray, and FACS, EarlyCell specializes in analyzing rare cells to provide precise diagnostic solutions. Founded in 2015, the company is headquartered in Cleveland, Ohio, USA.
EarlyCell has made significant strides in the field of genetic diagnostics, contributing to the improved detection and understanding of rare conditions. Its innovative approach has garnered attention within the biotech community, positioning it as a key player in the industry.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Genetic Diagnostics
Technology
Biotech
Tags
Healthtech
Model Types
Data Information, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was EarlyCell founded?
EarlyCell was founded in 2015.
Where is EarlyCell’s headquarters located?
EarlyCell’s headquarters is located in Cleveland, OH, US.
When was EarlyCell’s last funding round?
EarlyCell’s most recent funding round was for $800k (USD) in June 2015.
How many employees does EarlyCell have?
EarlyCell has 6 employees as of Feb 5, 2024.
How much has EarlyCell raised to-date?
As of July 05, 2023, EarlyCell has raised a total of $800k (USD) since Jun 25, 2015.
Add Comparison
Total Raised to Date
$800k
USD
Last Update Jun 25, 2015
Last Deal Details
$800k
USD
Jun 25, 2015
Seed
Total Employees Over Time
6
As of Feb 2024
EarlyCell Address
3615 Superior Ave
suite 4407b
Cleveland,
Ohio
44114
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts